Clonal trajectories of CH mutations during the evolution of 26 subsequent hematologic malignancies. Six CH genes were present in at least 3 patients who subsequently developed a hematologic malignancy that was also sequenced using the MSK IMPACT platform. Vector origins at time zero show CH VAF in blood, and vector termini show VAF in the bone marrow at time of hematologic disease characterization.